Chronic levetiracetam exposure has gender-related effects on bone health.
Long levetiracetam exposure was associated with beneficial bone effects in men.
Long levetiracetam exposure was associated with adverse bone effects in women.
Lumbar spine measures were more sensitive for detecting these gender differences.